New insight in physiopathology of preeclampsia and intra-uterine growth retardation: Role of inflammation;Avancées dans la physiopathologie de la pré-éclampsie: Place de la réponse inflammatoire

Gynecologie Obstetrique et Fertilite

Volumn 32, Issue 6, 2004, Pages 482-489

  Bretelle, F ^a   Sabatier, F ^a   Shojai, R ^b   Agostini, A ^b   Dignat George, F ^a   Blanc, B ^a   D'Ercole, C ^b  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL NORD   (France)

Author keywords

Inflammation; Intra uterine growth restriction; Preeclampsia; Pr clampsie; Retard de croissance intra ut rin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; MACROLIDE; NITRIC OXIDE; NITROFURANTOIN;

APOPTOSIS; ATHEROSCLEROSIS; CYTOKINE PRODUCTION; ENDOTHELIUM; HUMAN; HYPOTHESIS; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

EID: 3042560263     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.12.015     Document Type: Article

References (92)

1. Deeker G.A., Van Geijn H.P. Endothelial dysfunction in preeclampsia. Part I: Primary Prevention; therapeutic perspectives. J Perinat Med. 24:1996;99-100
2. Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D., Redman C.W.G. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynecol. 102:1995;20-25
3. Dekker G.A., Kraayenbrink A.A. Oxygen free radicals in preeclampsia. Am J Gynecol Obstet. 164:1991;273
4. Sattar N., Bendomir A., Berry C., Shepherd J., Greer I.A., Packard C.J. Lipoprotein subfraction concentrations in preeclampsia-pathogenic parallels to atherosclerosis. Obstet Gynecol. 89:1997;403-408
5. Chua S., Wilkins T., Sargent I., Redman C. Trophoblast deportation in preeclamptic pregnancy. Br J Obstet Gynecol. 98:1991;973-979
6. Wang Y.P., Walsh S.W. TNFalpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunology. 32:1996;157-169
7. Greer I.A., Haddad N.G., Johnstone F.D., Calder A.A. Neutrophil activation in pregnancy induced hypertension. Br J Obstet Gynecol. 96:1989;978-982
8. Kubes P., Suzuki M., Granger D.N. Nitric Oxide - An endogenous modulator of leukocyte adhesion. Proc. Natl Acad Sci. 88:1991;4651
9. Baker P.N., Davidge S.T., Barankiewicz J., Roberts J.M. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension. 27:1996;56-61
10. Seligman S.P., Buyon J.P., Clancy R.M. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 171:1994;944-950
11. Fickling S.A., Williams D., Vallance P., Nussey S.S., Whitley G.S. Plasma concentrations of endogenous inhibitor of nitric acid oxide synthesis in normal pregnancy and preeclampsia. Lancet. 342:1993;242-243
12. Savvidou M.D., Hingorani A.D., Tsikas D., Frolich J.C., Vallance P., Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet. 361:2003;15511-15517
13. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 111:(5):2003;649-658
14. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest. 111:2003;707-716
15. Luttun A., Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? J Clin Invest. 111:2003 March 1;600-602
16. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 222:1999;222-235
17. Walsh S.W. Maternal-placental interactions of oxidative stress and antioxidant in preeclampsia. Semin reprod Endocrinol. 16:1998;93-104
18. Davidge S.T. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol. 16:1998;1359-1375
19. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 179:1998;1359
20. Katusic Z.S., Vanhoutte P.J.M. Superoxide anion and endothelial regulation of arterial tone. Semin Perinatol. 15:1991;30
21. Yanik F.F., Ammanvermez R., Yanik A., Celik C., Koku A. Preeclampsia associated with increased lipid peroxidation and decreased serum vitamine E levels. Int J Gynaecol Obstet. 64:1999;27-33
22. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Cir Res. 85:1999;753-766
23. Stewart D.J., Monge J.C. Hyperlipidaemia and endothelial dysfunction. Curr Opin Lipidol. 4:1993;319
24. Lorentzen B., Endersen M.J., Clausen T., Henriksen T. Fasting serum free fatty acids and triglucerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy. 13:1994;103
25. Staff A.C., Ranheim T., Khoury J., Henriksen T. Incresased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol. 180:1999;587-592
26. Lehr H.A., Krombach F., Munzing Z. In Vitro effects of oxidized low-density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol. 146:1995;218
27. Lorentzen B., Endersen M.J., Hovig T., Henriksen T. Sera from preeclamptic women incresase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res. 63:1991;353
28. Takacs P., Kauma S.W., Sholley M.M., Walsh S.W., Dinsmoor M.J., Green K. Increased circulating rapid peroxides in severe preeclampsia activate NF-κ B and upregulate ICAM-1 in vascular endothelial cells. FASEB J. 15:2001;279-281
29. Kauma S., Takacs P., Scordalakes C., Walsh S., Green K., Peng T. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol. 1000:2002;706-714
30. Roberts J.M., Hubel C.A. Is Oxidative stress the link in the two-stage model of preeclampsia. Lancet. 354:1999;810-816
31. Von Dadelszen P., Magee L.A. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand. 81:2002;642-648
32. Faas M.M., Schuiling G.A. Preeclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol. 95:2001;213-217
33. Herrera J.A., Chaudhuri G., Lopez-Jaramillo P. Is infection a major risk for preeclampasia. Medical Hypotheses. 57:2001;393-397
34. Trogstad L.I.S., Eskild A., Bruu A.E., Jeansson S., Jenum P.A. Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand. 80:2001;1036-1038
35. Teran A., Escudero C., Moya W., Flores M., Vallance P., Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynecol Obstet. 75:2001;243-249
36. Sakawi Y., Tarpey M., Chen Y.F., Calhoum, Connor M.G., Chesnut D.H., Parks D.A. Evaluation of low dose endotoxin administration as amodel of Preeclamspia. Anesthesiology. 93:2000;1445-1446
37. Faas M.M., Schuiling G.A., Linton E.A., Sargent I.L., Redman C.W. Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol. 182:2000;351-357
38. Haller H., Hemel A., Homuth V. Endothelial cell permeability and proteine kinase C in preeclampsia. Lancet. 351:1998;945-949
39. Djurovic S., Schjetlein R., Wisloff F., Haugen G., Berg K. Increased levels of intercellular adhesion molecules and vascular cell adhesion in preeclampsia. Br J Obstet Gyneacol. 104:1997;466-470
40. Austgulen R., Lien E., Vince G., redman C.W. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, Eselectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 71:1996;53-58
41. Krauss T., Kuhn W., Lakoma C., Augustin H.G. Circulating endothelial cell adhesion molecules as diagnostic markers of early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol. 177:1997;443-449
42. Bretelle F., Sabatier F., Blann A., Boutiere B., Mutin M., D'ercole C., et al. Different profile in preeclampsia and isolated IUGR: comparison with normal pregnancy. BJOG. 108:2001;1277-1282
43. Johnson M.R., Anim-Nyame N., Johnson P., Sooranna S.R., Steer P.J. Does endothelial cell activation occur with intrauterine growth restriction? BJOG. 109:2002;836-839
44. Tsukimori K., Maeda H., Ishida K., Nagata H., Koyanagi T., Nakano H. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol. 81:1993;536-540
45. Sabatier F., Bretelle F., d'Ercole C., Boubli L., Sampol J., Dignat-George F. Neutrophil activation in preeclampsia and isolated intra uterine growth retardation. Am J Obstet Gynecol. 186:2000;1558-1563
46. Von Dadelszen P., Wilkins T., Redman C.W. Maternal peripheral blood leucocytes in normal and preeclamptic pregnancies. Br J Obstet Gynecol. 106:1999;576-581
47. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 161:1989;1200-1204
48. Pietersma A., De Jong N., Koster J.F., Sluiter W. Effect of hypoxia on adherence of granulocytes to endothelial cells in vitro. Am J Physiol. 267:(3 Pt 2):1994 Sep;H874-H879
49. Holmlund A., Hulthe J., Millgard J., Sarabi M., Kahan T., Lind L. Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis. 165:2002;271-276
50. Ruchaud-Sparagano M.H., Drost E.M., Donnelly S.C., Bird M.I., Haslett C., Dransfield I. Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol. 28:1998;80-89
51. Armstrong N.P.I., Teisner B., Redman C.W.G., Westergaard J.G., Fokersen J., Grudzinkas J.G. Complement activation, circulating protease inhibitors and pregnancy and pregnancy associated proteins in severe preeclampsia. Br J Obstet Gyneacol. 93:1986;811-814
52. Taufield P.A., Suthanthiran M., Ales K. Maternal-fetal immunity: presence of specific cellular hyporesponsivenness and humoral suppressor activity in normal pregnancy and their absence in preeclampsia. Clin Exp Hypertens. 2:1983;123-131
53. Saito S., Umekage H., Sakamoto Y., Sakai M., Tanebe K., Sasaki Y., et al. Increased T-Helper-1-type immunity and decreased T-helper-2 type immunity in patients with preeclampsie. Am J Reprod Immunol. 41:1999;297-306
54. Hojo M., Suthanthiran M., Helseth G., August P. Lymphocyte intracellular free calcium concentration is increased in preeclampsie. Am J Obstet Gynecol. 180:1999;1209-1214
55. Darmochwal-Kolarz D., Leszcynska-Gorzelak B., Rolinski J., Oleszczuck J. The expression and concentration of Fas/APO (CD95) antigen in patients with severe preeclampsia. J Reprod Immunol. 49:2001;153-164
56. Chiaworapongsa T., Gervasi M.T., Refuerzo J., Espinoza J., yoshimatsu, Berman S., et al. Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia. Am J Obstet Gynecol. 187:2002;889-893
57. Halligan A., Bonnar J., Shepard B., Darling M., Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia. Br J Obstet Gyneacol. 101:1994;488-492
58. Janes S.L., Goodall A.H. Flow cytometric detection of circulating activated platelets and platelets hyperresponsiveness in preeclampsia and pregnancy. Clin Sci. 86:1994;731-739
59. Mellembakken J.R., Solum N.O., Ueland T., Videm V., Aukrust P. Increased concentrations of soluble CD40 ligand RANTES and GRO-α in Preeclampsia-Possible role of Platelet activation. Thromb Haemostat. 86:2001;1272-1276
60. Bosio P.M., Cannon S., McKenna P.J., O'Herlihy C., Conroy R., Brady H. Plasma P-selectin is elevated in the first trimester in women who subsequently develop preeclampsia. BJOG. 108:2001;709-715
61. Konijnenberg A., van der Post J.A., Mol B.W., Schaap M.C.L., Lazarov R., Bleker O.P., Boer K., Sturk A. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia, a prospective study. Am J Obstet Gynecol. 177:1997;434-442
62. Jimenez M.F., Watson M.F., Parodo J., Evans D., Foster D., Steinberg M. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg. 132:1997;1263-1270
63. Huppertz B., Frank H.G., Kingdom J.C., Reister F., Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol. 110:1998;495-508
64. Leung T.N., Smith S.C., To K.F., Sahota D.S., Baker P.N. Increased placental apoptosis in pregnancies complicated with preeclampsie. J Soc Gynecol Invest. 6:1999;127
65. Levy R., Smith S.D., Chandler K., Sadovsky Y., Nelson D.M. Apoptosis in human cultured trophoblast is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell. 278:2000;982-988
66. Marin R., Gorostidi M., Portal C.G., Sanchez M., Sanchez E., Alvarez J. Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy. 19:2000;199-209
67. Chesley L.C. Recognition of the long-term sequelae of eclampsia. Am J Obstet Gynecol. 182:2000;249-250
68. De Wolf F., Brosens I., Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol. 87:1980;678-685
69. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 88:2001;10-15
70. Roberts J.M. Preeclampsia: what we know and what we do not know. Semin Perinatol. 24:2000;24-28
71. De Wolf F., Brosens I., Robertson W.B. Ultrastructure of uteroplacental arteries. Contrib Gynecol Obstet. 9:1982;86-99
72. Hendrix M.G., Salimans M.M., Van Boven C.P., Bruggeman C.A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 136:1990;23-28
73. Blasi F., Denti F., Erba M., Cosentini R., Raccanelli R., Rinaldi A., et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic anevrysms. J Clin Microbiol. 34:1996;2766-2769
74. Gurfinkel E. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective. J Infect Dis. 181:(Suppl 3):2000 Jun;S566-S568
75. Valantine H.A., Gao S.Z., Menon S.G., Renlund D.G., Hunt S.A., Oyer P., et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation. 100:1999;61-66
76. Laifer S.A., Ehrlich G.D., Huff D.S., Balsan M.J., Scantlebury V.P. Congenital cytomegalovirus infection in offspring of liver transplant recipients. Clin Infect Dis. 20:1995;52-55
77. Radcliffe J.J., Hart C.A., Francis W.J., Johnson P.M. Immunity to cytomegalovirus in women with unexplained recurrent spontaneous abortion. Am J Reprod Immunol Microbiol. 12:1986;103-105
78. Savige J.A., Gilbert G.L., Fairley K.F., McDowall D.R. Bacteriuria due to Ureaplasma urealyticum and Gardnerella vaginalis in women with preeclampsia. J Infect Dis. 148:1983;605
79. Gilbert G.L., Garland S.M., Fairley K.F., McDowall D.M. Bacteriuria due to ureaplasmas and other fastidious organisms during pregnancy: prevalence and significance. Pediatr Infect Dis. 5:1986;S239-S243
80. Mittendorf R., Lain K.Y., Williams M.A., Walker C.K. Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med. 41:1996;491-496
81. Offenbacher S., Lieff S., Boggess K.A., Murtha A.P., Madianos P.N., Champagne C.M., et al. Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. Ann Periodontol. 6:2001;164-174
82. Beck J.D., Pankow J., Tyroler H.A., Offenbacher S. Dental infections and atherosclerosis. Am Heart J. 138:1999;S528-S533
83. Knight M., Duley L., Henderson-Smart D.J., King J.F. Antiplatelet agents for preventing and treating preeclampsia. (Cochrane Review ). The Cochrane Library. 2000;Update Software, Oxford. Issue 1
84. Johansen M., Redman C.W., Wilkins T., Sargent I.L. Trophoblast deportation in human pregnancy-its relevance for preeclampsia. Placenta. 20:1999;531-539
85. Bretelle F., Combes V., Sabatier F., d'Ercole C., Dignat-George F. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intra uterine growth restriction. Thrombosis Haemostasis. 89:2003;486-492
86. Mesri M., Altieri D.C. Endothelial cell activation by leucocyte microparticles. J Immunol. 161:1998;4382-4387
87. Mesri M., Altieri D.C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem. 274:1999;23111-23118
88. Joop K., Berckmans R.J., Nieuwland R., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost. 85:2001;810-820
89. Miyamoto S., Kowalska M.A., Marcinkiewicz C., Marcinkiewicz M.M., Mosser D., Edmunds L.H., et al. Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates. Thromb Haemost. 80:1998;982-988
90. Cornejo C.J., Winn R.K., Harlan J.M. Anti-adhesion therapy. Adv Pharmacol. 39:1997;99-142
91. Haug C.E., Colvin R.B., Delmonico F.L. Aphase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation. 55:1993;766-772
92. Harlan J., Winn R.K. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med. 30:2002;214-219